Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
Annals of Gastroenterology|January 26, 2026
Prevalence of <i>Helicobacter pylori</i> infection and gastric intestinal metaplasia in Greek patientsStergios N Kouvaras, Ioannis G Koumarianos, Konstantinos Ekmektzoglou, et al.
Gut|November 1, 1996
Helicobacter pylori infection in spouses of patients with duodenal ulcers and comparison of ribosomal RNA gene patternsS D Georgopoulos, A F Mentis, C A Spiliadis, et al.
Annals of Gastroenterology|March 7, 2018
Hybrid therapy as first-line regimen for <i>Helicobacter pylori</i> eradication in a high clarithromycin resistance area: a prospective open-label trialSotirios D Georgopoulos, Vasilios Papastergiou, Beatriz Martinez-Gonzalez, et al.
Alimentary Pharmacology & Therapeutics|March 6, 2002
Effectiveness of two quadruple, tetracycline- or clarithromycin-containing, second-line, Helicobacter pylori eradication therapiesS D Georgopoulos, S D Ladas, S Karatapanis, et al.
Acta Gastro-Enterologica Belgica|November 23, 2011
"7, 10 and 14-days rabeprazole-based standard triple therapies for H. pylori eradication: are they still effective? A randomized trial"S Karatapanis, S D Georgopoulos, V Papastergiou, et al.
Radiation Protection Dosimetry|August 6, 2010
Underwater in situ measurements of radionuclides in selected submarine groundwater springs, Mediterranean SeaC Tsabaris, J Scholten, A P Karageorgis, et al.
Helicobacter|November 7, 2019
Helicobacter pylori eradication regimens in an antibiotic high-resistance European area: A cost-effectiveness analysisApostolis Papaefthymiou, Christos Liatsos, Sotirios D Georgopoulos, et al.
Antibiotics (Basel, Switzerland)|March 27, 2024
Equivalence Trial of the Non-Bismuth 10-Day Concomitant and 14-Day Hybrid Therapies for <i>Helicobacter pylori</i> Eradication in High Clarithromycin Resistance AreasSotirios D Georgopoulos, Elias Xirouchakis, Christos Liatsos, et al.
Medicina (Kaunas, Lithuania)|March 22, 2020
Evaluation of the Direct Economic Cost per Eradication Treatment Regimen against <i>Helicobacter pylori</i> Infection in Greece: Do National Health Policy-Makers Need to Care?Christos Liatsos, Apostolis Papaefthymiou, Nikolaos Kyriakos, et al.
European Journal of Internal Medicine|May 3, 2016
Randomized clinical trial comparing ten day concomitant and sequential therapies for Helicobacter pylori eradication in a high clarithromycin resistance areaSotirios D Georgopoulos, Elias Xirouchakis, Beatrice Martinez-Gonzales, et al.
Pageof 9